Susquehanna downgrades Sciele Pharma, Inc. (Nasdaq: SCRX) from Positive to Neutral.

Susquehanna analyst says, "Though we believe that Sciele ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE